In comparison, immunofluorescence or qPCR studies did not identify a distinct anti‐TIF‐1γ+‐specific biomarker that is associated with an increased risk of CAM showing that NanoString analysis is useful for better understanding of the DM etiology, prognosis, and identifying better treatment strategies. The gene discussed is TRIM33; the disease is dermatomyositis.